Sam Dawkins
Latest contributions
TAVI for bioprosthetic valve failure - LIVE Case
22 May 2025 – From EuroPCR 2025
A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...
The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients
22 May 2025 – From EuroPCR 2025
How do paravalvular leak, pacemaker implantation and reintervention planning shape lifetime outcomes in TAVI patients?
This session examines these crucial aspects through the case of a 77-year-old male with bicuspid aortic valve stenosis, HFpEF and multiple comorbidities, including diabetes, obesity and sleep apnoea.
Follow the discussion to understand...
New devices for structural interventions
21 May 2025 – From EuroPCR 2025
Discover emerging devices transforming structural heart interventions. This session highlights biomimetic valve designs, new transcatheter aortic valve systems, novel devices for aortic insufficiency, leaflet resection, left atrial appendage closure, and short self-expanding TAVR valves with promising early results.
Pioneering innovation in the treatment of mitral and tricuspid regurgitation
20 May 2025 – From EuroPCR 2025
This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...
Best of science and education in cardiovascular interventional medicine in 2024
16 Dec 2024
Dear Colleagues, dear PCR Companions,
As we welcome a new year, it is the perfect time to reflect on what we achieved together over the past year—both as a celebration of our successes and as motivation to continue improving in the year ahead.
2024 was a record year...
Management of transcatheter mitral complications: prevention, recognition and bailout
26 Nov 2024 – From PCR London Valves 2024
Curious about managing complications in transcatheter mitral interventions? Don’t miss this video!
You'll get step-by-step guidance on tackling real-world challenges (single leaflet detachment, device embolization...), and learn essential tips and tricks from experienced high-volume operators.
How to improve TAVI durability - LIVE case
26 Nov 2024 – From PCR London Valves 2024
Explore two fascinating cases tackling severe aortic valve challenges with innovative approaches:
- LIVE Case: An 84-year-old woman with a history of breast cancer and TAVI (Evolut Pro 29) in 2016, presenting with symptomatic severe TAVI stenosis. CT revealed a true ID of 19 mm. The team implanted...
TRISCEND II Pivotal Trial : How will TTVR impact the treatment of tricuspid regurgitation?
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Marianna Adamo, Philipp Lurz, and Sam Dawkins explore the one-year outcomes of the TRISCEND II Pivotal Trial, highlighting its potential to redefine the management of severe tricuspid regurgitation. They delve into the trial’s impact on patients’ quality of life, examine its limitations,...
Mitral valve: PCR London Valves 2024 highlights
26 Nov 2024 – From PCR London Valves 2024
Chiara De Biase interviews Sam Dawkins and Francesco Maisano about the PCR London Valves 2024 highlights on mitral valve disease. They highlight sessions analyzing the latest trial evidence, including the two-year data from the MiCLASP and CLASP IID studies. The Congress also stands out for its...
Tricuspid TEER - Advanced skills
25 Nov 2024 – From PCR London Valves 2024
Want to take your tricuspid TEER skills to the next level? Watch this video!
You’ll discover how to tackle common anatomical challenges, improve your imaging techniques with tools like intra-cardiac echocardiography and learn expert strategies for managing complex cases. Don't miss these valuable tips and tricks!
Tailoring tricuspid interventions with the EVOQUE and PASCAL Precision systems
25 Nov 2024 – From PCR London Valves 2024
Catch up on this engaging session, featuring a parallel case study of two high-risk patients with severe tricuspid regurgitation. Discover how the PASCAL system is used to treat diverse TR anatomies and explore patient selection and management strategies for the EVOQUE system. Watch a recorded case...
Meet the masters: M-TEER
24 Nov 2024 – From PCR London Valves 2024
Curious about the key strategies for successful mitral TEER? Don’t miss this video where top experts in the field share their experiences and provide practical advice on tackling the procedure.
Get valuable insights into case selection, procedural strategies and complication management, and watch as experienced operators reveal...
How to establish a mitral TEER programme
24 Nov 2024 – From PCR London Valves 2024
Ready to start your journey toward establishing a mitral TEER programme? This video covers everything you need to know—from understanding the contemporary role of TEER in managing mitral regurgitation to building a Heart Team and referral network.
Learn how to find your first cases, select the right...
Innovation for transcatheter tricuspid interventions - LIVE case
24 Nov 2024 – From PCR London Valves 2024
Dive into the world of innovation for transcatheter tricuspid interventions. Discuss the remaining challenges associated with currently available options, capture the central role of imaging guidance, and understand the anatomical selection criteria for transcatheter tricuspid valve replacement. Experience a live case from St. Thomas' Hospital, London,...
Leading innovation for patients with valvular heart disease
24 Nov 2024 – From PCR London Valves 2024
Discover the newest advancements in transcatheter heart valves and their role in modern lifetime management of valvular heart disease. Review the latest clinical outcomes demonstrating improved patient care and explore how a diverse device portfolio addresses a wide range of valve anatomies.
Severe tricuspid regurgitation: repair or replace?
15 Nov 2024
An 87-year-old male patient with severe tricuspid regurgitation, a history of pacemaker implantation, and atrial fibrillation seeks advanced treatment options to improve his declining exercise capacity and daily activities.
Author
PASCAL Precision system simulation showcase: grasp the difference!
16 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 session, explore a transcatheter edge-to-edge mitral valve repair case, delve into discussions backed by simulation, evidence, and real-world cases to understand atraumatic clasp and closure techniques and predictable implant release. Additionally, gain insights into real-world evidence for tricuspid TEER from the EuroTR trial...
Pacemaker lead and the tricuspid valve: navigating challenges for optimal care
16 May 2024 – From EuroPCR 2024
This session focuses on the complex interplay between pacemaker leads and the tricuspid valve, addressing the anatomical interactions, procedural challenges, and alternative pacing strategies. Attendees will gain a better understanding of the impact of pacemaker leads on tricuspid regurgitation, the techniques for lead implantation and extraction,...
Complicated scenarios in LAA occlusion
15 May 2024 – From EuroPCR 2024
Explore this session to discover strategies for handling complications during and after LAA occlusion, examine scenarios where LAA occlusion can serve as a secondary intervention, and review complex cases like embolised occluders, combined MitraClip and LAA procedures, and unexpected events in patient management.
TEER for primary mitral regurgitation - LIVE case
15 May 2024 – From EuroPCR 2024
A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...
TEER for primary mitral regurgitation
18 Feb 2024 – From PCR Tokyo Valves 2024
What are the current indications and future perspectives of using TEER for primary mitral regurgitation? Join this session if you want to gain insight into anatomical evaluation before TEER, learn the procedural strategy for complex primary mitral regurgitation, and explore the specific features of both MitraClip...
Challenging situations in mitral valve interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
This selection of cases showcases a number of challenging situations in mitral valve interventions and how best to resolve them. Among such complications are a severe afterload mismatch following M-TEER in functional mitral regurgitation, a detached clip in the left atrium, and more.
New possibilities in TEER
18 Feb 2024 – From PCR Tokyo Valves 2024
Watch this session to get an overview of a new TEER device, follow the step-by-step procedure related to initial experiences with this device for a Japanese patient with degenerative mitral regurgitation, learn about the latest data from RCT and registries, and follow discussions of challenging TEER...
Primary mitral regurgitation edge to edge repair with one device - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 83-year-old male presented symptomatic severe PMR due to lateral P2 chordal rupture, small LA and preserved LV function (68%). Watch the operators implant one XTW clip successfully.
LIVE case from Sendai Kousei Hospital - Sendai, Japan
Navigate the video by moving your mouse over the chapter icon in...
Contemporary surgical and transcatheter approaches for multivalve disease
21 Nov 2023 – From PCR London Valves 2023
Explore modern surgical and transcatheter strategies for addressing multivalve disease in this session: gain in-depth knowledge about the current approaches in both surgical and transcatheter management of multivalve disease, develop a profound understanding of algorithms guiding the identification of the dominant valve lesion and shaping procedural...
Transcatheter tricuspid edge-to-edge repair step-by-step
21 Nov 2023 – From PCR London Valves 2023
In this interactive session, the comprehensive case of an 81-year-old patient with atrial fibrillation, coronary artery disease and chronic kidney disease, presenting with fatigue, shortness of breath and peripheral oedema, is dissected, allowing meticulous analysis of each step of transcatheter edge-to-edge tricuspid valve repair. Don't miss...
Treating a wide range of patient anatomies with the PASCAL implants
06 Dec 2023 – From PCR London Valves 2023
Sam Dawkins, Niklas Schofer and Mirjam Wild share the latest experience on Pascal implants for mitral and tricuspid TEER. Together they discuss the rationale for using the same device for mitral and tricuspid, how the skills and knowledge on MR can be used for TR,...
Complex transcatheter mitral and tricuspid interventions - Recorded cases
20 Nov 2023 – From PCR London Valves 2023
This session features two compelling cases of percutaneous annuloplasty for advanced heart failure and massive tricuspid regurgitation:
- Left ventricular restoration in heart failure with reduced ejection fraction
A 56-year-old male, with type 2 diabetes, hypertension and chronic kidney disease, presented a symptomatic severe LV dysfunction (26%) and severely...
The EVOQUE and PASCAL Precision systems in action: simulation- and case-based learning
20 Nov 2023 – From PCR London Valves 2023
This session explores the features of the PASCAL Precision and the EVOQUE tricuspid replacement systems through simulators and case presentations, while a panel of experts discuss the technology, witnessing live demonstrations of treating mitral and tricuspid regurgitation patients.
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
